GEMTUZUMAB OZOGAMICIN FOR RELAPSED OR PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA IN CHILDREN EXPERIENCE OF THE POLISH PEDIATRIC LEUKEMIA AND LYMPHOMA STUDY GROUP (PPLLSG)

被引：0

作者：

Pawinska-Wasikowska, Katarzyna ^{[1
]}

Bukowska-Strakova, Karolina ^{[2
]}

Czogala, Malgorzata ^{[1
]}

Ksiazek, Teofila ^{[3
]}

Skalska-Sadowska, Jolanta ^{[4
]}

Samborska, Magdalena ^{[5
]}

Wachowiak, Jacek ^{[4
]}

Chaber, Radoslaw ^{[6
]}

Tomaszewska, Renata ^{[7
]}

Szczepanski, Tomasz ^{[8
]}

Zielezinska, Karolina ^{[9
]}

Urasinski, Tomasz ^{[10
]}

Moj-Hackemer, Malgorzata ^{[11
]}

Kalwak, Krzysztof ^{[12
]}

Kozlowska, Marta ^{[13
]}

Irga-Jaworska, Ninela ^{[13
]}

Balwierz, Walentyna ^{[1
]}

Skoczen, Szymon ^{[14
]}

机构：

[1] Jagiellonian Univ, Inst Pediat, Dept Pediat Oncol & Hematol, Med Coll, Krakow, Poland

[2] Jagiellonian Univ, Inst Pediat, Dept Clin Immunol, Med Coll, Krakow, Poland

[3] Jagiellonian Univ, Inst Pediat, Dept Med Genet, Med Coll, Krakow, Poland

[4] Poznan Univ Med Sci, Dept Pediat Oncol Hematol & Transplantol, Poznan, Poland

[5] Oznan Univ Med Sci, Dept Pediat Oncol Hematol & Transplantol, Poznan, Poland

[6] Univ Rzeszow, Inst Med Sci, Dept Pediat, Med Coll, Rzeszow, Poland

[7] Med Univ Silesia, Dept Pediat Hematol & Oncol, Zabrze, Poland

[8] Med Univ Silesia SUM, Dept Pediat Hematol & Oncol, Zabrze, Poland

[9] Pomeranian Med Univ, Dept Paediat Hematol & Oncol & Gastroenterol, Szczecin, Poland

[10] Pomeranian Med Univ, Dept Pediat Hematooncol & Gastroenterol, Szczecin, Poland

[11] Univ Wroclaw, Dept Bone Marrow Transplantat Pediat Oncol & Hema, Wroclaw, Poland

[12] Wroclaw Med Univ, Dept & Clin Pediat Oncol Hematol & Bone Marrow Tr, Wroclaw, Poland

[13] Med Univ Gdansk, Dept Pediat Hematol & Oncol, Gdansk, Poland

[14] Jagiellonian Univ, Univ Childrens Hosp, Dept Paediat Oncol & Haematol, Coll Medicum, Krakow, Poland

来源：

PEDIATRIC BLOOD & CANCER | 2023年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO024

引用

页码：S552 / S552

页数：1

共 50 条

[21] Gemtuzumab ozogamicin in acute myeloid leukemia
C D Godwin
R P Gale
R B Walter
Leukemia, 2017, 31 : 1855 - 1868
[22] Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia
Yahagi, Yuichi
Usui, Noriko
Yamaguchi, Yuko
Dobashi, Nobuaki
Yano, Shingo
Takei, Yutaka
Sugiyama, Katsuki
Takahara, Shinobu
Ogasawara, Yoji
Saito, Takeshi
Kasama, Kinuyo
Yokoyama, Hiroki
Kamiyama, Yutaro
Katsube, Atsushi
Aiba, Keisuke
BLOOD, 2012, 120 (21)
[23] Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia
Chowdhury, Saeeda
Seropian, Stuart
Marks, Peter W.
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (09) : 599 - 600
[24] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
Naoko Hosono
Miyuki Ookura
Hiroaki Araie
Mihoko Morita
Kazuhiro Itoh
Yasufumi Matsuda
Takahiro Yamauchi
International Journal of Hematology, 2021, 113 : 362 - 369
[25] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
Hosono, Naoko
Ookura, Miyuki
Araie, Hiroaki
Morita, Mihoko
Itoh, Kazuhiro
Matsuda, Yasufumi
Yamauchi, Takahiro
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 362 - 369
[26] The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia
Hien K. Duong
Matt Kalaycio
Current Hematologic Malignancy Reports, 2009, 4 (2) : 55 - 56
[27] Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia
Abedin, Sameem M.
Badar, Talha
Gauger, Katelyn
Michaelis, Laura C.
Runaas, Lyndsey
Carlson, Karen-Sue
Murthy, G. S. Guru
Atallah, Ehab
LEUKEMIA RESEARCH, 2022, 123
[28] Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
Walter, Roland B.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S95 - S96
[29] TREATMENT RESULTS OF CHILDREN AND ADOLESCENTS WITH HODGKIN LYMPHOMA: REPORT OF POLISH PEDIATRIC LEUKEMIA LYMPHOMA STUDY GROUP (PPLLSG)
Balwierz, W.
Klekawka, T.
Moryl-Bujakowska, A.
Matysiak, M.
Sopylo, B.
Chybicka, A.
Chaber, R.
Szczepanski, T.
Janik-Moszant, A.
Wachowiak, J.
Kaczmarek-Kanold, M.
Kowalczyk, J. R.
Mitura-Lesiuk, M.
Balcerska, A.
Stachowicz-Stencel, T.
Wysocki, M.
Koltan, A.
Krawczuk-Rybak, M.
Muszynska-Roslan, K.
Mlynarski, W.
Stolarska, M.
Sobol, G.
Mizia-Malarz, A.
Wieczorek, M.
Pietka, T.
Karolczyk, G.
Urbanek-Dadela, A.
Urasinski, T.
Kamienska, E.
PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 883 - 883
[30] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
Giles, F
Estey, E
O'Brien, S
CANCER, 2003, 98 (10) : 2095 - 2104

← 1 2 3 4 5 →